Literature DB >> 16327163

Particulate and microbial contamination in in-use admixed parenteral nutrition solutions.

Shigeharu Oie1, Akira Kamiya.   

Abstract

We evaluated particulate and microbial contamination in a total of 192 samples of in-use admixed and unadmixed parenteral nutrition solutions remaining in infusion bags in 10 hospitals. The mean numbers (range) of drug glass ampoules, plastic ampoules, and vials used in a total of 192 admixed solutions were 3.38 (1-13), 0.79 (0-7), and 1.2 (0-8), respectively. The mean number of particles (range) contained in the 192 samples according to the particle size (diameter) was 960.9 (30-9,539)/ml for particles >or=1.3 microm, 42.8 (0-587)/ml for those >or=5 microm, 6.4 (0-146)/ml for those >or=10 microm, and 0.09 (0-1)/ml for those >or=50 microm. The number of particles >or=1.3 microm in diameter was significantly higher in the 192 samples than in 7 samples (controls) of solutions not mixed with any ampoule or vial (p<0.0001). In addition, the number of particles >or=1.3 microm in diameter was significantly higher in samples of solutions mixed with 4-13 glass ampoules than in those of solutions mixed with 1-3 glass ampoules (p<0.01). On the other hand, none of the 199 samples showed bacteria or fungi/5 ml residual solution. Measures against particulate contamination of admixed parenteral nutrition solutions are necessary.

Mesh:

Substances:

Year:  2005        PMID: 16327163     DOI: 10.1248/bpb.28.2268

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Analysis of particulate contaminations of infusion solutions in a pediatric intensive care unit.

Authors:  Thomas Jack; Bernadette E Brent; Martin Boehne; Meike Müller; Katherina Sewald; Armin Braun; Armin Wessel; Michael Sasse
Journal:  Intensive Care Med       Date:  2010-02-18       Impact factor: 17.440

2.  In-line filtration reduces severe complications and length of stay on pediatric intensive care unit: a prospective, randomized, controlled trial.

Authors:  Thomas Jack; Martin Boehne; Bernadette E Brent; Ludwig Hoy; Harald Köditz; Armin Wessel; Michael Sasse
Journal:  Intensive Care Med       Date:  2012-04-12       Impact factor: 17.440

3.  The effect of different methods of intravenous injection on glass particle contamination from ampules.

Authors:  Ga Eul Joo; Kyeong-Yae Sohng; Michael Yong Park
Journal:  Springerplus       Date:  2016-01-06

4.  A large amount of microscopic precipitates are inevitably injected during infusion therapy without an in-line filter.

Authors:  Shinya Shimoyama; Daisuke Takahashi; Syuhei Arai; Yuji Asami; Kimiko Nakajima; Kentaro Ikeda; Takumi Takizawa; Tomio Kobayashi
Journal:  Oxf Med Case Reports       Date:  2022-02-19

5.  In-line filtration minimizes organ dysfunction: new aspects from a prospective, randomized, controlled trial.

Authors:  Martin Boehne; Thomas Jack; Harald Köditz; Kathrin Seidemann; Florian Schmidt; Michaela Abura; Harald Bertram; Michael Sasse
Journal:  BMC Pediatr       Date:  2013-02-06       Impact factor: 2.125

6.  Influence of in-line microfilters on systemic inflammation in adult critically ill patients: a prospective, randomized, controlled open-label trial.

Authors:  Ilse Gradwohl-Matis; Andreas Brunauer; Daniel Dankl; Elisabeth Wirthel; Ingeborg Meburger; Angela Bayer; Michaela Mandl; Martin W Dünser; Wilhelm Grander
Journal:  Ann Intensive Care       Date:  2015-11-04       Impact factor: 6.925

7.  Effectiveness of in-Line Filters to Completely Remove Particulate Contamination During a Pediatric Multidrug Infusion Protocol.

Authors:  Maxime Perez; Bertrand Décaudin; Wadih Abou Chahla; Brigitte Nelken; Laurent Storme; Morgane Masse; Christine Barthélémy; Gilles Lebuffe; Pascal Odou
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

8.  In-line filtration of intravenous infusion may reduce organ dysfunction of adult critical patients.

Authors:  Elke Schmitt; Patrick Meybohm; Eva Herrmann; Karin Ammersbach; Raphaela Endres; Simone Lindau; Philipp Helmer; Kai Zacharowski; Holger Neb
Journal:  Crit Care       Date:  2019-11-22       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.